Administration of recombinant thrombomodulin before progression of disease causing disseminated intravascular coagulation might be better compared with administration after progression of disease
Crossref DOI link: https://doi.org/10.1186/s40560-014-0049-0
Published Online: 2014-08-22
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yatabe, Tomoaki
Nakamura, Ryu
Kumagai, Naoko
Iiyama, Tatsuo
Yamashita, Koichi
Yokoyama, Masataka
License valid from 2014-08-22
Article History
Received: 11 March 2014
Accepted: 11 August 2014
First Online: 22 August 2014